Verve Therapeutics Reports Durable and Well-Tolerated Editing of[...]
Verve Therapeutics to Participate in Upcoming May Investor Conferences
Verve Therapeutics Reports Additional VERVE-101 and GalNAc-Lipid[...]
01/20/2022 | Press release | Distributed by Public on 01/19/2022 23:27
Please select the service you want to use:
Smartlinks | Worksport Ltd. | News | Company News | Business Announcement | Products and Services | Public Companies | Business Support Service Companies | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | NYSE Chicago
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact